Foley attorneys filed an amicus brief in the United States District Court for the Southern District of New York related to ACLU v. Myriad regarding subject matter patentability of gene patents specifically on isolated DNA. The authors conclude that the U.S. Congress, U.S. courts and the USPTO, as well as the scientific community and biotechnology industry have long relied upon an understanding that claims directed to “isolated DNA” recite patentable subject matter under 35 U.S.C. §101 and the Constitution. The authors maintain that to hold otherwise would have a dramatic negative effect on biotech research as we know it, and will influence the entire business of biotechnology in ways unforeseen or addressed by the plaintiffs in ACLU v. Myriad”
People
Related News
22 May 2025
Press Releases
Foley Continues Expansion in California with Two Corporate Partners in Silicon Valley
Foley & Lardner LLP announced today that it has expanded its Innovative Technology Sector and Transactions Practice Group with the addition of partners Gurpreet Bal and Shaalu Mehra to the firm’s Silicon Valley office. Both attorneys bring substantial experience advising technology companies, investors, and founders on complex transactional and corporate matters.
12 May 2025
Press Releases
Foley Expands East Coast Litigation Bench, Adds Three Partners in New York and Raleigh
Foley & Lardner LLP announced today that it has strengthened its East Coast presence with the addition of three partners to its Litigation Department.
08 May 2025
Press Releases
Foley Expands Technology and Energy Capabilities with Addition of Two Digital Infrastructure Partners
Foley & Lardner LLP announced today the addition of partners Daniel Farris and Joe McClendon to its Chicago office, further enhancing the firm’s Technology Transactions, Cybersecurity, and Privacy Practice and its Energy & Infrastructure and Innovative Technology Sectors.